Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Randall Smith and Alden Global’s Best Investment Idea $GCI

Randall Smith’s Alden Global Capital is very bullish on Gannett Co Inc (GCI). GCI is extremely undervalued. It is trading at a stable 30% free flow cash yield, has only $2 billion in debt  and is trading at just 5.09 times its earnings. Sure, it’s a newspaper company but it has a great stable of titles and stations, not to mention a 2.90% dividend yield. It also has strong free cash flow. GCI is trading at $10.80 right now, but analysts are predicting the stock will go as high as $21 in the next 12 months.

Gannett Co., Inc. (NYSE:GCI)

The company has around $2 billion in digital assets , including popular names like Career Builder and Classified Ventures. Once the digital assets are combined with its core newspaper operations, GCI has an aggregated value of $10 billion. Even subtracting the $2 billion debt the company owes, it is delivering $8 billion of value for its $2.5 billion market cap. Even if the bottom falls out, the company’s market cap is more than its debt. In other words, GCI is grossly undervalued.

Randall Smith has more than $132 million invested in the company. Several other hedge fund managers are bullish on GCI as well, including Ariel Investments’ John W. Rogers, who has almost $187 million in the company (see John Rogers‘ top picks), and the venerable Warren Buffett, who has almost $25 million of Berkshire Hathaway’s fund invested in GCI (check out Warren Buffett‘s top picks).

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!